This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Sapience Therapeutics, Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Barry Jay Kappel: Innovator in Peptide Technology
Introduction
Barry Jay Kappel is a notable inventor based in Pelham, NY (US). He has made significant contributions to the field of peptide technology, holding a total of four patents. His work focuses on innovative solutions that have the potential to impact medical science.
Latest Patents
Among his latest patents are the ATF5 peptide variants and their uses. These patents describe ATF5 peptides that feature a truncated ATF5 leucine zipper region and, optionally, a cell-penetrating region. The compositions comprising these ATF5 peptides are designed for methods that inhibit proliferation and promote cytotoxicity in neoplastic cells. This innovative approach could lead to advancements in cancer treatment.
Career Highlights
Barry Kappel is currently associated with Sapience Therapeutics, Inc., where he continues to develop his groundbreaking work in peptide technology. His career is marked by a commitment to advancing scientific knowledge and improving therapeutic options.
Collaborations
He has collaborated with notable colleagues, including Jimmy Andrew Rotolo and Gene Merutka, contributing to a dynamic research environment that fosters innovation.
Conclusion
Barry Jay Kappel's contributions to peptide technology exemplify the spirit of innovation in the medical field. His patents and ongoing work at Sapience Therapeutics, Inc. highlight the potential for significant advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile